NYSE: WEAVWeave Communications Inc Stock
$9.31-0.07 (-0.75%)
Updated Apr 17, 2025
WEAV Price
$9.31
Fair Value Price
N/A
Market Cap
$688.01M
52 Week Low
$8.10
52 Week High
$17.63
P/E
-23.28x
P/B
10.27x
P/S
5.58x
PEG
N/A
Dividend Yield
N/A
Revenue
$204.31M
Earnings
-$28.35M
Gross Margin
71.4%
Operating Margin
-13.04%
Profit Margin
-13.9%
Debt to Equity
1.82
Operating Cash Flow
$14M
Beta
1.51
Next Earnings
May 22, 2025
Ex-Dividend
N/A
Next Dividend
N/A
WEAV Overview
Weave Communications Incorporated provides customer communications and engagement software in the US and Canada. Offerings include Customized Phone System, a smarter phone system that identifies whether incoming calls are from new or current customers, provides information at every call, and manages heavy call times. Other, integrated, offerings are Weave Text Messaging to communicate with customers and Weave Team, an inters and intra-office group messaging solution. Weave Communications was founded in 2008 and is headquartered in Lehi, UT.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WEAV's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
WEAV
Ranked#14 of 44
Ranked#14 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important WEAV news, forecast changes, insider trades & much more!
WEAV News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WEAV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WEAV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WEAV is poor value based on its book value relative to its share price (10.27x), compared to the US Health Information Services industry average (3.39x)
P/B vs Industry Valuation
WEAV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more WEAV due diligence checks available for Premium users.
Valuation
WEAV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-23.28x
Industry
11.14x
Market
27.98x
WEAV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
10.27x
Industry
3.39x
WEAV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WEAV's financial health
Profit margin
Revenue
$54.2M
Net Income
-$6.7M
Profit Margin
-12.4%
WEAV's Earnings (EBIT) of -$26.63M... subscribe to Premium to read more.
Interest Coverage Financials
WEAV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$188.9M
Liabilities
$122.0M
Debt to equity
1.82
WEAV's short-term assets ($120.74M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WEAV's short-term assets ($120.74M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WEAV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
WEAV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$6.7M
Investing
-$611.0k
Financing
-$5.6M
WEAV's operating cash flow ($14.15M)... subscribe to Premium to read more.
Debt Coverage Financials
WEAV vs Health Information Service Stocks
Weave Communications Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.